Prevalence ofChlamydia trachomatisamong Childbearing Age Women in India: A Systematic Review.
Background. Infection withChlamydia trachomatis(CT) can lead to reproductive sequelae. Information on the general population of childbearing age women in India is sparse. We reviewed the literature on CT prevalence within the general population of reproductive aged women in order to improve the efforts of public health screening programs and interventions.Objective. To conduct a literature review to determine the prevalence ofChlamydia trachomatisamong childbearing age women in India.Search Strategy. Ovid Medline and PubMed databases were searched for articles from January 1, 2003, through December 31, 2014. Search terms included "Chlamydia trachomatis", "CT", "prevalence", "India", and "sexually transmitted infections".Selection Criteria. Studies on prevalence data for CT among women of childbearing age (15-45) living in India were included.Data Collection and Analysis. Articles that met the inclusion criteria were extracted by two readers and discrepancies solved through discussion.Results. Reported prevalence of active CT infection among lower risk groups ranged from 0.1% to 1.1% and in higher risk group from 2.7% to 28.5%.Conclusion.CT prevalence among women in India is comparable to other countries. Screening programs to prevent adverse outcomes among Indian women of childbearing age and their offspring are warranted.
SHARE India, MIMS, Hyderabad, India.
Kalpana
0000-0002-0164-0515
K
Betha
STRATUS Center for Medical Simulation, Brigham and Women's Hospital, Boston, MA, USA.
Jamie M
JM
Robertson
Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Gong
G
Tang
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Catherine L
CL
Haggerty
Prev Med. 2003 Apr;36(4):502-9
12649059
Ann Intern Med. 2007 Jul 17;147(2):89-96
17638719
Pediatrics. 2009 Dec;124(6):1505-12
19933728
PLoS One. 2012;7(5):e34794
22567090
J Clin Microbiol. 2003 Jun;41(6):2700-2
12791909
JAMA. 1990 Jun 20;263(23):3164-7
2348526
Sex Transm Dis. 2002 Jan;29(1):1-5
11773871
Braz J Infect Dis. 2011 Nov-Dec;15(6):533-9
22218511
Hum Fertil (Camb). 2010 Sep;13(3):115-25
20849196
Glob J Health Sci. 2013 Feb 24;5(3):139-49
23618483
Aust N Z J Obstet Gynaecol. 2013 Aug;53(4):338-46
23870029
Sex Transm Dis. 2010 Mar;37(3):159-64
19901864
Hum Reprod Update. 1999 Sep-Oct;5(5):433-47
10582782
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):253-7
19525855
Arch Gynecol Obstet. 2013 Oct;288(4):747-57
23793551
Can Fam Physician. 2007 Oct;53(10):1739-41
17934039
J Infect Dis. 1988 Sep;158(3):510-7
3045213
Am Fam Physician. 2012 Dec 15;86(12):1127-32
23316985
Asian J Androl. 2008 Jan;10(1):110-4
18087650
Sex Transm Infect. 1999 Feb;75(1):3-17
10448335
N Engl J Med. 1996 May 23;334(21):1362-6
8614421
Indian J Dermatol Venereol Leprol. 2009 Nov-Dec;75(6):614-6
19915249
Int J STD AIDS. 2004 Jan;15(1):51-5
14769173
Med J Aust. 2012 Dec 10;197(11):642-6
23230936
Ann Clin Microbiol Antimicrob. 2010 Sep 08;9:24
20822551
PLoS Med. 2009 Jul 21;6(7):e1000097
19621072